Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review.
Tetyana B Kendzerska, Peter M Smith, Romina Brignardello-Petersen...
https://pubmed.ncbi.nlm.nih.gov/24135493/Actively Recruiting
Led by Henry M. Jackson Foundation for the Advancement of Military Medicine · Updated on 2026-01-08
222
Participants Needed
2
Research Sites
87 weeks
Total Duration
Researchers are evaluating the Symptom-Targeted Approach to Rehabilitation for Concussion STAR-C in adults with a history of mild traumatic brain injury mTBI. The study aims to compare the effects of in-person STAR-C, telehealth STAR-C, and no treatment on reducing everyday cognitive complaints. The trial also seeks to understand how patient characteristics affect treatment response and to develop a plan for wider use of STAR-C in clinical settings. Participants are randomly assigned to one of three groups a four-week no treatment waitlist, in-person cognitive rehabilitation, or telehealth cognitive rehabilitation. Those receiving treatment will have up to nine sessions plus a wrap-up session over several weeks. Therapy focuses on compensatory strategies, personalized goals, and homework practice to help make strategy use a habit. The wrap-up session helps participants plan to maintain their progress. During the study, participants complete questionnaires and assessments at baseline, immediately post-treatment, and at one- and three-month follow-ups. Outcome measures include the Common Concussive Cognitive Complaints C4 and Goal Attainment Scaling GAS to track improvement and maintenance. Researchers will also gather feedback from patients and clinicians to guide future implementation. The total duration of participation varies but includes treatment and follow-up visits over several months.
CONDITIONS
Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C)
M
Marc Blaylock
K
Kalawena N Kalehuawehe
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead Sponsor
Brooke Army Medical Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) | No-Treatment Waitlist | Compensatory Cognitive Training (CCT), Guideline-Endorsed Cognitive Rehabilitation |
|---|---|---|---|
| What is it? | STAR-C is a therapist-guided cognitive rehabilitation program focusing on strategy use, repeated practice, and learning new facts or concepts. Each session includes structured practice and homework to help participants build cognitive strategies into daily life. | Waitlist participants do not receive any therapist-delivered cognitive rehabilitation during the main study interval. They undergo usual monitoring without active cognitive strategy training. | CCT is a therapist-guided cognitive rehabilitation program designed to address cognitive complaints after mTBI using structured training, compensatory strategies, and real-world functional improvement. |
| Role in the study | STAR-C is the primary intervention arm, with assignment by randomization to either in-person or telehealth delivery. | Waitlist is the randomized control group for outcome comparison, receiving no cognitive rehabilitation during the study period. | CCT represents guideline-endorsed cognitive rehabilitation typically offered in real-world clinical care for persistent cognitive symptoms after mTBI. |
| Primary use | STAR-C aims to improve memory, attention, and executive function through personalized strategies and high-dose spaced practice, addressing cognitive complaints following concussion. | Waitlist serves as a comparator to measure the effect of STAR-C, with no proactive intervention targeting cognitive complaints. | CCT is used for improving cognitive symptoms after mild TBI, supporting long-term functional outcomes for patients with persistent complaints. |
| How is it given or performed? | Delivered by a clinician in-person or via telehealth sessions. Sessions include strategy training, repeated practice, and between-session homework targeting cognitive goals. | No active intervention given. Participants may access usual care and monitoring, but do not receive study-related cognitive rehabilitation during the main phase. | CCT is delivered by a trained clinician in-person (or remotely when supported), with weekly sessions focusing on cognitive strategies, compensatory training, and structured practice between visits. |
| Evidence status | STAR-C is adapted from evidence-based cognitive rehabilitation methods, but no published results yet exist for this specific protocol; clinical effectiveness is under investigation. | No-treatment waitlist arms serve as controls in rehabilitation studies; evidence supports use as a comparator but does not address effectiveness for symptom improvement. | CCT is supported by randomized clinical trial evidence for improving cognitive symptoms after mTBI and by systematic reviews endorsing its clinical use in guideline recommendations. |
| Important limitations | STAR-C is a shortened adaptation, with efficacy and durability not yet established for this specific protocol. The study does not randomize against other guideline-endorsed interventions. | Waitlist control does not represent active cognitive rehabilitation and may not reflect clinical practice for persistent symptoms. Duration of observed improvement is typically limited to the study window. | CCT is not universally available in all clinical settings. Results from published studies may vary depending on population, severity, and access to qualified therapists. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 4 weeks
Participants randomized to this group will wait for 4 weeks without treatment while maintaining their current treatments. They will complete questionnaires about their symptoms during this time.
1 visit (in-person or remote) at end of wait period
Duration - Up to 4 weeks (up to nine sessions plus one wrap-up session)
Participants receive individual in-person cognitive rehabilitation treatment with up to three sessions per week focusing on compensatory strategies, personalized targets, and weekly homework assignments. The treatment ends with a wrap-up session to plan maintenance.
Up to 10 visits (in-person)
Duration - Up to 4 weeks (up to nine sessions plus one wrap-up session)
Participants receive individual cognitive rehabilitation treatment via telemedicine with up to three sessions per week focusing on compensatory strategies, personalized targets, and weekly homework assignments. The treatment ends with a wrap-up session to plan maintenance.
Up to 10 visits (remote)
Duration - 3 months
Participants are followed for 3 months after treatment to evaluate maintenance of treatment effects and overall progress.
1 visit at 3 months post treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Tetyana B Kendzerska, Peter M Smith, Romina Brignardello-Petersen...
https://pubmed.ncbi.nlm.nih.gov/24135493/Douglas B Cooper, Amy O Bowles, Jan E Kennedy...
https://pubmed.ncbi.nlm.nih.gov/27603763/Christy A Blevins, Frank W Weathers, Margaret T Davis...
https://pubmed.ncbi.nlm.nih.gov/26606250/Tessa Hart, Theodore Tsaousides, Jeanne M Zanca...
https://pubmed.ncbi.nlm.nih.gov/24370323/K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941/Sarah L Martindale, Leah V Farrell-Carnahan, Christi S Ulmer...
https://pubmed.ncbi.nlm.nih.gov/28703617/Isabelle Boutron, Douglas G Altman, David Moher...
https://pubmed.ncbi.nlm.nih.gov/28630973/M W Johns
https://pubmed.ncbi.nlm.nih.gov/1798888/Peter J Hoover, Caitlyn A Nix, Juliana Z Llop...
https://pubmed.ncbi.nlm.nih.gov/35023563/Adam R Kinney, Addie Middleton, James E Graham
https://pubmed.ncbi.nlm.nih.gov/33667720/Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead Sponsor
Brooke Army Medical Center
Collaborating Sponsor